ERBB2 and breast carcinoma: The key steps in this approach are (1) extraction of exosomes (HER2 positive/negative) from breast cancer patients and (2) subsequent capture by the aptameric HER2 region of the capture probe anchored to the chip surface, and exposing the G4 DNA sequence (3).